The 2025 State of Pharma Launch Excellence Industry Report has just been released, and you can download it now.

The pharmaceutical industry is entering a pivotal phase as launches grow more complex, particularly with the rise of specialty drugs and cutting-edge therapies like antibody-drug conjugates (ADCs), cell and gene therapies, and mRNA-based treatments. In 2025, the adoption of generative AI and advanced digital tools will significantly accelerate the launch process, driving faster development times, enhancing decision-making, and boosting patient engagement. Companies that can harness these technologies while navigating regulatory hurdles and healthcare system challenges will be best positioned for success in this evolving landscape.

Download your complimentary copy of the brand new 45 page report now for an in-depth look at:

• How generative AI is transforming pharma launch strategies
• Key therapeutic areas like oncology, immunology, and obesity treatments leading future launches
• Navigating new regulatory challenges, including U.S. price controls and European reforms
• The critical role of cross-functional coordination in achieving launch success
• Why specialty drugs continue to dominate market growth
• The rise of independent launches by smaller biotech firms
• Addressing healthcare system capacity issues amid rising specialty drug costs